Nucleoside modified mRNA vaccines for infectious diseases

Methods in Molecular Biology

Volumn 1499, Issue , 2017, Pages 109-121

  Pardi, Norbert ^a   Weissman, Drew ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Infectious diseases; Lipid nanoparticles; Messenger RNA; Modified nucleoside; Pseudouridine; Vaccine

Indexed keywords

LIPID; MESSENGER RNA; NANOPARTICLE; NUCLEOSIDE; RNA VACCINE; 1-METHYLPSEUDOURIDINE; PSEUDOURIDINE; VACCINE;

FAST PROTEIN LIQUID CHROMATOGRAPHY; INFECTION; NONHUMAN; PURIFICATION; VACCINATION; ANALOGS AND DERIVATIVES; ANIMAL; ANTIBODY PRODUCTION; B LYMPHOCYTE; CHEMISTRY; COMMUNICABLE DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOLOGY; MOUSE; PROCEDURES; T LYMPHOCYTE;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMMUNICABLE DISEASES; LIPIDS; MICE; NANOPARTICLES; NUCLEOSIDES; PSEUDOURIDINE; RNA, MESSENGER; T-LYMPHOCYTES; VACCINATION; VACCINES;

EID: 85007198666     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-6481-9_6     Document Type: Chapter

References (18)

1. Yang B, Jeang J, Yang A et al (2014) DNA vaccine for cancer immunotherapy. Hum Vaccin Immunother 10:3153–3164
2. Villarreal DO, Talbott KT, Choo DK et al (2013) Synthetic DNA vaccine strategies against persistent viral infections. Expert Rev Vaccines 12:537–554
3. Petsch B, Schnee M, Vogel AB et al (2012) Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection. Nat Biotechnol 30:1210–1216
4. Geall AJ, Verma A, Otten GR et al (2012) Nonviral delivery of self-amplifying RNA vaccines. Proc Natl Acad Sci U S A 109:14604–14609
5. Hekele A, Bertholet S, Archer J et al (2013) Rapidly produced SAM((R)) vaccine against H7N9 influenza is immunogenic in mice. Emerg Microbes Infect 2:e52
6. Brito LA, Chan M, Shaw CA et al (2014) A cationic nanoemulsion for the delivery of next-generation RNA vaccines. Mol Ther 22:2118–2129
7. Bogers WM, Oostermeijer H, Mooij P et al (2015) Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion. J Infect Dis 211:947–955
8. Routy JP, Boulassel MR, Yassine-Diab B et al (2010) Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy. Clin Immunol 134:140–147
9. Van Gulck E, Vlieghe E, Vekemans M et al (2012) mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. AIDS 26:F1–F12
10. Allard SD, De Keersmaecker B, de Goede AL et al (2012) A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption. Clin Immunol 142:252–268
11. Kariko K, Buckstein M, Ni H et al (2005) Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23:165–175
12. Kariko K, Muramatsu H, Welsh FA et al (2008) Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther 16: 1833–1840
13. Kariko K, Muramatsu H, Ludwig J et al (2011) Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res 39:e142
14. Pardi N, Tuyishime S, Muramatsu H et al (2015) Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J Control Release. doi:10.1016/j.jconrel.2015.08.007
15. Klechevsky E (2013) Human dendritic cells - stars in the skin. Eur J Immunol 43:3147–3155
16. Pardi N, Muramatsu H, Weissman D et al (2013) In vitro transcription of long RNA containing modified nucleosides. Methods Mol Biol 969:29–42
17. Weissman D, Pardi N, Muramatsu H et al (2013) HPLC purification of in vitro transcribed long RNA. Methods Mol Biol 969:43–54
18. Semple SC, Akinc A, Chen J et al (2010) Rational design of cationic lipids for siRNA delivery. Nat Biotechnol 28:172–176